VN
EN
Close Menu
Home page
About Us
About Imexpharm
Our Culture
Our Journey
People
Potential
News
Imexpharm News
Events
Specialized
Investor Events
Community Activities
Products
Product Groups
Products A-Z
Investors
Investor events
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Corporate Governance
Search All
Our Charter
Management Regulations
Corporate Governance Reports
Prospectus
Code of Conduct
Community
Careers
Media
Contact
Home
Investors
Investor documents
Search All
Search All
AGM
BOD Resolutions
Information Disclosure
IR News
Financial Statements
Annual Reports
Sustainability Reports
Search All
Close Filter
Find report
Search
05/24/2024
IMP - BOD Resolution No. 07 dated May 23, 2024 approving the receipt of credit limits from commercial banks in 2024
05/24/2024
IMP - BOD Resolution No. 06 dated May 23, 2024 re. the selection of auditing firm in 2024
05/23/2024
IMP- IMEXPHARM 1Q2024 EARNINGS CALL INVITATION
05/06/2024
Annual Report 2023 (digital version)
04/27/2024
Imexpharm’s Internal regulations on corporate governance - April, 2024
04/15/2024
IMP - Information disclosure: Announcing the 2023 Annual Report link
04/05/2024
IMP - Documents of the 2024 AGM
03/28/2024
IMP - Information disclosure: Explanation of 2023 financial statements
03/27/2024
IMP - Audited Financial Statements for the year end 31 Dec 2023
03/26/2024
IMP - Notice of invitation to the 2024 AGM
View document
«
‹
1
2
3
4
5
6
7
8
9
10
›
»